Document is current
Any future updates will be listed below
-
Authors
Rönnholm, John
Weiner, Sophia
Fuchs, Johannes
Thorsell, Annika
Sihlbom, Carina
Dugom, Laura
Easton, Amy
Zetterberg, Henrik
Gobom, Johan
-
Funding
Funding for this research was provided by:
University of Gothenburg
- License Information
-
More Information
Article History
Received: 9 November 2025
Accepted: 4 February 2026
First Online: 15 February 2026
Declarations
:
: Surplus volume from CSF and plasma samples from the Clinical Routine Neurochemistry Laboratory at the Sahlgrenska University Hospital were used for method development after de-identification to prevent that they can be traced back to an individual patient, in accordance with the Swedish Biobank law (Biobanks in Medical Care Act) and the Swedish ethical legislation (The Act concerning the Ethical Review of Research Involving Humans). CSF samples from the Target ALS foundation were collected in accordance with an informed consent procedure and subject to applicable ethical approvals.
: Not applicable.
: The authors declare no competing interests.
